Deparment of Immunology
Moffitt Cancer Center
United States of America
Dr. John Mullinax is affiliated to Deparment of Immunology, Moffitt Cancer Center. Dr. John Mullinax is currently providing services as Researcher. Dr. John Mullinax has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. John Mullinax contributions have acclaimed recognition from honourable subject experts around the world. Dr. John Mullinax is actively associated with different societies and academies. Dr. John Mullinax academic career is decorated with several reputed awards and funding. Dr. John Mullinax research interests include focused on immunotherapy for soft tissue sarcoma.
Focused on immunotherapy for soft tissue sarcoma
Mullinax JE, Kroon HM, Thompson JF, Nath N, Mosca PJ, Farma JM, Bhati R, Hardmann D, Sileno S, O'Donoghue C, Perez M, Naqvi SM, Chen YA, Gonzalez RJ, Zager JS. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. J Am Coll Surg. 2017 Apr;224(4):635-642.
Mullinax JE, Gonzalez RJ, Zager JS. Treatment of Soft Tissue Sarcoma: In reply to He and colleagues. J Am Coll Surg. 2017 Aug;225(2):349.
Naghavi AO, Gonzalez RJ, Scott JG, Kim Y, Abuodeh YA, Strom TJ, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB, Fernandez DC. Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma. J Contemp Brachytherapy. 2017 Feb;9(1):20-29.